Retinal patients in Croatia now have access to a new formulation of EYLEA, provided in an 8 mg dosage.
Assist Prof Nataša Drača, PhD, MD was the first ophthalmologist in the country to administer this 8 mg injection for treating wet macular degeneration and diabetic macular edema.This medication allows for improved disease management with fewer injections. By offering treatment with EYLEA 8 mg, Klinika Svjetlost continues to pioneer advancements in global ophthalmology, enhancing patient care through ongoing innovation.
